ArticleHealth science reports2025
Air Way Management in Mini-Surgical Percutaneous Dilatational Tracheostomy Using Endotracheal Tube and Supraglottic Airway Devices (I-Gel, Laryngeal Mask Airway, and LarySeal) Classical and Ultrasound Point of View: A Prospective Cohort Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Mini-surgical percutaneous dilatational tracheostomy (msPDT) offers a streamlined alternative to conventional tracheostomy, yet the optimal airway management device for this procedure remains underexplored. This study compares the efficacy and safety of endotracheal tubes (ETTs) versus supraglottic airway devices (SADs: I-gel, LMA, LarySeal) during msPDT. Methods: In this prospective cohort study, 464 mechanically ventilated patients underwent msPDT between 2015 and 2023. Patients were stratified into four groups: ETT ( Results: Procedural time was shortest with LMA (1.8 ± 0.65 min) and I-gel (1.9 ± 0.62 min), compared to ETT (2.2 ± 0.68 min) and LarySeal (2.0 ± 0.66 min). The LarySeal group exhibited a higher pneumothorax incidence (7.1% vs. 0%-2.2% in other groups, Conclusion: I-gel and LMA optimize msPDT efficiency and safety, while LarySeal's anatomical interference warrants caution. Ultrasound-guided device selection enhances procedural precision, advocating for SADs as first-line tools in msPDT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.